Female X chromosome RNA (XIST) as a possible trigger for autoimmune disease
"Lnc"ing XIST Ribonucleoprotein Particles to Female Sex-Attributed Biases in Autoimmunity
This project looks at whether a female-specific RNA called XIST and its partner proteins can trigger immune reactions that help explain why autoimmune diseases affect women more often.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11128219 on NIH RePORTER |
What this research studies
If I took part, researchers would first expose immune cells in the lab to XIST ribonucleoprotein particles to see if they provoke an immune response. They would also use a genetically engineered mouse that expresses Xist in males to observe whether Xist increases autoimmune disease in animals. Finally, they would test blood serum from people with autoimmune diseases to see if patient antibodies react to XIST complexes. Together these steps aim to link a female-specific genetic mechanism to immune triggers that might explain higher autoimmunity rates in XX individuals.
Who could benefit from this research
Good fit: Ideal candidates would be adults with autoimmune diseases—particularly women—who are willing to provide blood samples for serum testing.
Not a fit: People without autoimmune disease or whose condition is unrelated to X-chromosome biology are unlikely to receive direct benefit from this project.
Why it matters
Potential benefit: If confirmed, this work could reveal new biomarkers or treatment targets to improve diagnosis or therapies for autoimmune diseases, especially in women.
How similar studies have performed: This is largely a novel approach: although the X chromosome has been linked to autoimmune risk before, testing XIST ribonucleoprotein particles as direct immune triggers is new.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Dou, Diana Remy — Duke University
- Study coordinator: Dou, Diana Remy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.